Neuropharmacological Basis of Social Connection: The Role of Opioids
From birth we rely on others for comfort and care and derive pleasure from being together. Research from the fields of health psychology, social psychology, and public health converge to highlight the importance of having and maintaining good relationships for overall health. Indeed, having close friends and family and feeling connected to them has been called a basic need, similar to our need for food and water. It may not be a coincidence then that feelings of connection rely on similar systems in the body as other needs that are both basic and highly pleasing and rewarding. For instance, its possible that opioids, a substance in the body associated with pleasant, euphoric feelings, may also be important for connecting with others. This study will examine the role of opioids in feeling connected to others by administering a drug called naltrexone, that effects opioid processing in the body, on perceptions and feelings toward a number of tasks in the lab. Additionally, to assess the effects of naltrexone outside of the lab, participants will complete daily diary responses via text and online surveys.
40 participants will take both placebo and naltrexone. Participants will complete two sessions, one in each drug condition, in which they complete a number of tasks including reading messages on a computer screen, holding a number of objects, and viewing images while undergoing electric shocks. Participants will also complete a daily diary for 14 days while on naltrexone and placebo. Prior to these lab sessions participants will be screened at UCLA's Clinical & Translational Research Center (CTRC) to ensure that they are healthy and that it is safe for them to take the study drug.
We hypothesize that people will report feeling less socially connected when on naltrexone compared to placebo and will show subsequent changes in social behavior outside of the lab.
Studieoversigt
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
California
-
Los Angeles, California, Forenede Stater, 90095-1563
- University of California, Los Angeles Department of Psychology
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
Inclusion criteria for the study require that participants be in good health, between the ages of 18 and 35, fluent in English, have access to text messaging technology, and have at least 8 close friends and family members who would be willing to be contacted in regards to the study (for the social connection lab task) and be willing to provide 2 pictures of a close other (for the threat of shock task).
Exclusion Criteria:
Following an email screening and structured telephone interview, prospective participants with the following conditions will not advance to the in- person screening session: pregnant or planning to become pregnant in the next 6 months, presence of chronic mental or physical illness, history of allergies, liver, or other severe chronic diseases, current and regular use of prescription medications, or previous history of fainting during blood draws.
Furthermore, the absence of significant health problems or medication use history will be confirmed by an in-person screening session. Any participant who has any of the following conditions will be ineligible for the study: (1) Any and all medical conditions, especially hepatitis or liver failure.
Psychiatric Disorders. (2) current and/or lifetime history of a major Depressive Disorder or other Diagnostic and Statistical Manual Diploma in Social Medicine (DSM-IV) psychiatric disorder (e.g. substance dependence) (3) current and/or past regular use of analgesics such as opioids; (4) current and/or past regular use of psychotropic medications, including selective serotonergic reuptake inhibitors, antidepressants, anxiolytics, hypnotics, sedatives and barbiturates. Health factors. (5) current smokers (13) body mass index (BMI) greater than 35, (14) shows evidence of drug use from a urine test, (15) has a positive pregnancy test, if female, or (16) shows any abnormalities on screening laboratory tests.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Grundvidenskab
- Tildeling: Randomiseret
- Interventionel model: Crossover opgave
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: Naltrexone
Participants will take 4 doses of naltrexone over 4 days (25mg/day for days 1 and 2, 50mg/day for days 3 and 4) as well as 4 matched placebo pills for a total of 8 days. Capsules will be packaged into blister packs. Participants will be asked to take the first drug, either naltrexone or placebo, once a day for three days prior to the first experimental session and when they arrive at the lab for the experimental procedure . After the first session, participants will take the second study drug for three days prior to the second experimental session and when they arrive for the second experimental procedure. |
Andre navne:
|
|
Placebo komparator: Placebi
Participants will take 4 doses of naltrexone over 4 days (25mg/day for days 1 and 2, 50mg/day for days 3 and 4) as well as 4 matched placebo pills for a total of 8 days. Capsules will be packaged into blister packs. Participants will be asked to take the first drug, either naltrexone or placebo, once a day for three days prior to the first experimental session and when they arrive at the lab for the experimental procedure . After the first session, participants will take the second study drug for three days prior to the second experimental session and when they arrive for the second experimental procedure. |
Andre navne:
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Changes in Self-reported Feelings of Connection During Naltrexone (vs. Placebo)
Tidsramme: participants will report on their feelings of connection during two separate lab visits, on day 4 of each drug assignment
|
Participants will read positive, loving messages from friends and family members and then rate their feelings of connection (how connected, touched, and warm they felt, α = .93,
averaged to create a measure of feelings of social connection).
Ratings were made on a 1-7 scale anchored by "not at all" and "very."
Higher numbers indicate greater feelings of connection in response to reading the loving messages.
|
participants will report on their feelings of connection during two separate lab visits, on day 4 of each drug assignment
|
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Daily Self-reported Feelings of Social Connection
Tidsramme: end of day for 8 days
|
For 8 days (4 while on placebo, 4 while on naltrexone), participants were asked to think back to the last 24 hours and respond to how disconnected they felt ("I felt out of touch and disconnected from others").
Ratings were made on a 1-7 scale anchored by 'strongly disagree' and 'strongly agree.'
For ease of interpretation, feelings of disconnection were reverse-coded to measure daily feelings of social connection.
Thus higher numbers indicate greater feelings of connection.
Responses were averaged across the 4 days that participants were on each study drug (4 while on placebo, 4 while on naltrexone).
|
end of day for 8 days
|
Andre resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Self-reported Physical Symptoms
Tidsramme: once a day for 8 days
|
At the end of each day while on a study drug (4 days when on naltrexone and 4 days when on placebo) participants reported on their physical symptoms (headaches, dizziness/faintness, nausea, appetite increase/decrease) on a 0 (no symptoms) to 4 (very severe) scale. Responses were averaged across study drug to evaluate a single outcome for days when participants were on naltrexone and a single outcome for days when participants were on placebo. |
once a day for 8 days
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- Opioids and Social Cognition
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Psykologi, Social
-
German University of Health and SportsAfsluttet
-
Virginia Commonwealth UniversityNational Center for Advancing Translational Sciences (NCATS)AfsluttetPsykologi, Social | Social interaktion | Interpersonelle relationer | Adfærd, SocialForenede Stater
-
University of Maryland, College ParkEunice Kennedy Shriver National Institute of Child Health and Human Development...AfsluttetPeer gruppe | Social udstødelse | Fordomme, race | Fordomme | SexismeForenede Stater
-
University of British ColumbiaVancouver Foundation; Inner-City Women's Initiatives SocietyAfsluttetEnsomhed | Social støtte | Social isolationCanada
-
University of PadovaAktiv, ikke rekrutterendeEnsomhed | Social isolation hos ældre voksneItalien
-
Hospices Civils de LyonAfsluttet
-
Aya Technologies LimitedAfsluttetSocial angst | Social angst | Social angst (social fobi)Det Forenede Kongerige
-
Temple UniversityNational Institute on Disability, Independent Living, and Rehabilitation...Rekruttering
-
University of North Carolina, Chapel HillNational Institute on Minority Health and Health Disparities (NIMHD)Tilmelding efter invitation
-
IU University of Applied SciencesUniversity of Bologna; DLR German Aerospace Center; University of Lorraine; European Space Agency og andre samarbejdspartnereTilmelding efter invitationSunde voksne | Isolation, social | Høj højdeTyskland
Kliniske forsøg med Naltrexon
-
Mayo ClinicUniversity of TorontoRekrutteringFedme | Vægttab | Schizo affektiv lidelse | Bipolar I lidelse | Bipolar II lidelse | GLP - 1Forenede Stater
-
Yale UniversityNational Institute on Alcohol Abuse and Alcoholism (NIAAA)AfsluttetAlkohol afhængighed | Humant immundefektvirus | AIDS | Farligt drikkeri | Problem med at drikkeForenede Stater
-
Alkermes, Inc.Afsluttet
-
Alkermes, Inc.Afsluttet
-
Alkermes, Inc.Afsluttet
-
University of Alabama at BirminghamNational Institute of Neurological Disorders and Stroke (NINDS)Ikke rekrutterer endnuMyalgisk Encephalomyelitis/Kronisk træthedssyndromForenede Stater
-
San Diego State UniversityNational Institute on Drug Abuse (NIDA)RekrutteringPlacebo | NaltrexonForenede Stater
-
State University of New York - Upstate Medical...CephalonAfsluttetAlkohol afhængighed | Skizofreni | Skizoaffektive lidelser | Bipolære lidelserForenede Stater
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)Afsluttet
-
New York State Psychiatric InstituteNational Institute on Drug Abuse (NIDA)AfsluttetHeroinafhængighed | OpiatafhængighedForenede Stater